Bimatoprost is a mixed inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme: A potential treatment target for sex hormone-dependent diseases.

KM Marshall; OH Zarroug; DP Fischer; Anna Nicolaou; K Watanabe; DF Woodward

Bimatoprost is a mixed inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme: A potential treatment target for sex hormone-dependent diseases.

KM Marshall, OH Zarroug, DP Fischer, Anna Nicolaou, K Watanabe, DF Woodward

Pharmacy

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - Dec 2015
Event	British Pharmacol Society, - London Duration: 15 Dec 2015 → 17 Dec 2015

Conference

Conference	British Pharmacol Society,
City	London
Period	15/12/15 → 17/12/15

Cite this

@conference{30292e47aae443a6996ffbd0704ac1be,

title = "Bimatoprost is a mixed inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme: A potential treatment target for sex hormone-dependent diseases.",

author = "KM Marshall and OH Zarroug and DP Fischer and Anna Nicolaou and K Watanabe and DF Woodward",

year = "2015",

month = dec,

language = "English",

note = "British Pharmacol Society, ; Conference date: 15-12-2015 Through 17-12-2015",

}

TY - CONF

T1 - Bimatoprost is a mixed inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme: A potential treatment target for sex hormone-dependent diseases.

AU - Marshall, KM

AU - Zarroug, OH

AU - Fischer, DP

AU - Nicolaou, Anna

AU - Watanabe, K

AU - Woodward, DF

PY - 2015/12

Y1 - 2015/12

M3 - Poster

T2 - British Pharmacol Society,

Y2 - 15 December 2015 through 17 December 2015

ER -